A detailed history of Susquehanna International Group, LLP transactions in Neogenomics Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 28,747 shares of NEO stock, worth $431,492. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,747
Previous 37,567 23.48%
Holding current value
$431,492
Previous $521,000 18.62%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$13.4 - $17.73 $118,188 - $156,378
-8,820 Reduced 23.48%
28,747 $424,000
Q2 2024

Aug 15, 2024

BUY
$13.01 - $15.77 $488,746 - $592,431
37,567 New
37,567 $521,000
Q4 2023

Feb 14, 2024

BUY
$11.67 - $20.73 $294,737 - $523,556
25,256 Added 51.46%
74,339 $1.2 Million
Q3 2023

Nov 14, 2023

SELL
$12.15 - $17.85 $419,952 - $616,967
-34,564 Reduced 41.32%
49,083 $603,000
Q2 2023

Aug 11, 2023

SELL
$14.1 - $19.83 $1.7 Million - $2.39 Million
-120,701 Reduced 59.07%
83,647 $1.34 Million
Q1 2023

May 16, 2023

BUY
$9.09 - $19.45 $1.41 Million - $3.02 Million
155,123 Added 315.13%
204,348 $3.56 Million
Q4 2022

Feb 14, 2023

SELL
$6.45 - $12.07 $674,192 - $1.26 Million
-104,526 Reduced 67.98%
49,225 $454,000
Q3 2022

Nov 14, 2022

SELL
$7.86 - $12.91 $483,319 - $793,848
-61,491 Reduced 28.57%
153,751 $1.32 Million
Q2 2022

Aug 15, 2022

BUY
$7.06 - $13.97 $1.02 Million - $2.02 Million
144,302 Added 203.41%
215,242 $1.75 Million
Q4 2021

Feb 14, 2022

SELL
$30.49 - $48.49 $117,081 - $186,201
-3,840 Reduced 5.14%
70,940 $2.42 Million
Q3 2021

Nov 15, 2021

BUY
$41.66 - $52.52 $2.27 Million - $2.86 Million
54,484 Added 268.45%
74,780 $3.61 Million
Q2 2021

Aug 11, 2021

SELL
$36.62 - $51.69 $2.07 Million - $2.93 Million
-56,630 Reduced 73.62%
20,296 $917,000
Q1 2021

May 17, 2021

SELL
$41.56 - $59.88 $840,301 - $1.21 Million
-20,219 Reduced 20.81%
76,926 $3.71 Million
Q4 2020

Feb 16, 2021

BUY
$36.08 - $56.47 $2.8 Million - $4.38 Million
77,623 Added 397.62%
97,145 $5.23 Million
Q3 2020

Nov 16, 2020

SELL
$33.26 - $40.48 $687,118 - $836,276
-20,659 Reduced 51.41%
19,522 $720,000
Q2 2020

Aug 14, 2020

SELL
$24.21 - $31.02 $723,757 - $927,342
-29,895 Reduced 42.66%
40,181 $1.25 Million
Q1 2020

May 15, 2020

SELL
$20.5 - $34.53 $1.05 Million - $1.77 Million
-51,210 Reduced 42.22%
70,076 $1.94 Million
Q4 2019

Feb 14, 2020

SELL
$18.96 - $29.84 $969,292 - $1.53 Million
-51,123 Reduced 29.65%
121,286 $3.55 Million
Q3 2019

Nov 14, 2019

BUY
$19.12 - $26.24 $1.19 Million - $1.63 Million
62,299 Added 56.58%
172,409 $3.3 Million
Q2 2019

Aug 16, 2019

BUY
$19.57 - $24.1 $1.03 Million - $1.27 Million
52,703 Added 91.81%
110,110 $2.42 Million
Q4 2018

Feb 14, 2019

SELL
$11.24 - $18.5 $6,350 - $10,452
-565 Reduced 0.97%
57,407 $724,000
Q2 2018

Aug 14, 2018

BUY
$7.99 - $14.05 $463,196 - $814,506
57,972 New
57,972 $760,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.89B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.